Google's AI video tool, Veo, offers a compelling alternative to OpenAI's Sora for creating healthcare advertising videos. While both tools demonstrate impressive capabilities, Veo 3.1 stands out for its enhanced realism and narrative control. MM+M's testing revealed that Veo 3.1 can produce highly realistic videos, often indistinguishable from real-life footage. This level of realism is a significant advantage over Sora, where AI humans sometimes appear to have a 'halo' effect, detracting from the overall authenticity. However, the question arises: can these tools be misused to spread healthcare misinformation? Google's safety code filters aim to prevent harmful content, but MM+M's tests uncovered potential vulnerabilities. The tool generated a jarringly realistic ad claiming acetaminophen causes autism, despite the absence of supporting evidence. This incident highlights the importance of responsible AI usage and the need for human oversight. Marketers must consider the implications of relying solely on AI tools for creative content. While Veo and Sora can generate powerful healthcare messaging, they may not fully replace human creativity and empathy. Adam Daley, a social media expert, warns against replacing current processes with AI, emphasizing the value of authentic patient stories and the potential loss of trust if AI campaigns are mishandled. The industry must navigate the balance between innovation and ethical considerations, ensuring that AI tools enhance rather than replace the human touch in healthcare marketing.
